Paraganglioma overview: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (33 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Paraganglioma}} | {{Paraganglioma}} | ||
{{CMG}} | {{CMG}} {{AE}} | ||
==Overview== | ==Overview== | ||
==Historical Perspective== | |||
==Historical | |||
==Classification== | ==Classification== | ||
==Pathophysiology== | |||
==Causes== | |||
==Differentiating Xyz from Other Diseases== | |||
==Epidemiology and Demographics== | |||
==Risk Factors== | |||
==Screening== | |||
==Natural History, Complications, and Prognosis== | |||
==Diagnosis== | |||
===Diagnostic Study of Choice=== | |||
===History and Symptoms=== | |||
===Physical Examination=== | |||
===Laboratory Findings=== | |||
===Electrocardiogram=== | |||
===X-ray=== | |||
===Echocardiography and Ultrasound=== | |||
===CT scan=== | |||
===MRI=== | |||
===Other Imaging Findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | |||
===Medical Therapy=== | |||
=== Interventions === | |||
===Surgery=== | |||
===Primary Prevention=== | |||
===Secondary Prevention=== | |||
==References== | ==References== | ||
{{reflist|2}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category: | [[Category:Endocrinology]] | ||
[[Category: | |||
[[Category: | |||
Latest revision as of 23:35, 29 July 2020
|
Paraganglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Paraganglioma overview On the Web |
|
American Roentgen Ray Society Images of Paraganglioma overview |
|
Risk calculators and risk factors for Paraganglioma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: